Final phase II results of NCI 6981: A phase I/II study of sorafenib (S) plus gemcitabine (GEM) and capecitabine (CAP) for advanced renal cell carcinoma (RCC).
Year: 2011
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: S. T. Tagawa, A. Saran, N. H. Akhtar, S. Goel, G. Mileo, S. Kung, H. Beltran, M. I. Milowsky, M. Mazumdar, J. J. Wright, D. M. Nanus
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2591235542